|4Nov 17, 7:53 PM ET

GRAHAM RICHARD A 4

4 · Theravance Biopharma, Inc. · Filed Nov 17, 2022

Insider Transaction Report

Form 4
Period: 2022-11-16
GRAHAM RICHARD A
SVP, Development
Transactions
  • Tax Payment

    Ordinary Shares

    2022-11-16$11.20/sh2,800$31,360342,954 total

Documents

1 file
  • 4
    form4-11182022_121128.xmlPrimary